Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family

E-ISSN： 1873-5592|10|2|94-103

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.2, 2009-02, pp. : 94-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor

By Hu Bin Du Hui-Juan Yan Guo-Ping Zhuo Ren-Xi Wu Yuan Fan Chang-Lie

Drug Delivery, Vol. 21, Iss. 3, 2014-05 ,pp. : 204-212

Informa Healthcare

Access to resources Recommend Favorite

Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 124-131

Bentham Science Publishers

Access to resources Recommend Favorite

The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3337-3352

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 6, 2016-05 ,pp. : 486-494

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer therapies targeted to the epidermal growth factor receptor and its family members

By Kane Susan E

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 147-164

Informa Healthcare

Access to resources Recommend Favorite